WPE_6899_460x337.jpg

Lipidstoffwechsel

Sie befinden sich hier:

Lipidstoffwechsel

Autor Titel/Link Jahr Journal
Abella et al. Leptin in the interplay of inflammation, metabolism and immune system disorders. 2017 Nature reviews. Rheumatology
Giuranna et al. Genetische Ursachen der Adipositas 2017 Der Gastroenterologe
Heymsfield and Wadden Mechanisms, Pathophysiology, and Management of Obesity. 2017 The New England journal of medicine
Karathanasis et al. The Changing Face of HDL and the Best Way to Measure It. 2017 Clinical chemistry
Khvorova Oligonucleotide Therapeutics - A New Class of Cholesterol-Lowering Drugs. 2017 The New England journal of medicine
McGarrah et al. A Novel Protein Glycan-Derived Inflammation Biomarker Independently Predicts Cardiovascular Disease and Modifies the Association of HDL Subclasses with Mortality. 2017 Clinical chemistry
Miller and Shyy Context-Dependent Role of Oxidized Lipids and Lipoproteins in Inflammation. 2017 Trends in endocrinology and metabolism: TEM
Abdullahi and Jeschke White Adipose Tissue Browning: A Double-edged Sword. 2016 Trends in endocrinology and metabolism: TEM
Ajufo and Rader Recent advances in the pharmacological management of hypercholesterolaemia. 2016 Lancet Diabetes Endocrinol
Cingolani and Czaja Regulation and Functions of Autophagic Lipolysis. 2016 Trends in endocrinology and metabolism: TEM
Cushman and Goff More HOPE for Prevention with Statins. 2016 N Engl J Med
Hai and Zuo Aberrant DNA methylation in the pathogenesis of atherosclerosis. 2016 Clin Chim Acta
Han Lipidomics for studying metabolism. 2016 Nature reviews. Endocrinology
Ioannou The Role of Cholesterol in the Pathogenesis of NASH. 2016 Trends Endocrinol Metab
Jin et al. Apoprotein C-III: A review of its clinical implications. 2016 Clinica chimica acta; international journal of clinical chemistry
Kotani et al. Evidence-based assessment of lipoprotein(a) as a risk biomarker for cardiovascular diseases - Some answers and still many questions. 2016 Critical reviews in clinical laboratory sciences
Mammen Statin-Associated Autoimmune Myopathy. 2016 N Engl J Med
Nordestgaard et al. Fasting Is Not Routinely Required for Determination of a Lipid Profile: Clinical and Laboratory Implications Including Flagging at Desirable Concentration Cutpoints-A Joint Consensus Statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. 2016 Clinical chemistry
Pownall and Gotto New Insights into the High-Density Lipoprotein Dilemma. 2016 Trends Endocrinol Metab
Ramasamy Update on the molecular biology of dyslipidemias. 2016 Clin Chim Acta
Santos et al. Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel. 2016 The lancet. Diabetes & endocrinology
Stancel et al. Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of Atherosclerosis. 2016 Clin Chem
Vaziri HDL abnormalities in nephrotic syndrome and chronic kidney disease. 2016 Nat Rev Nephrol
Wald et al. Child-Parent Familial Hypercholesterolemia Screening in Primary Care. 2016 The New England journal of medicine
Xue-Shan et al. Imbalanced cholesterol metabolism in Alzheimer's disease. 2016 Clin Chim Acta
Yang and Han Lipidomics: Techniques, Applications, and Outcomes Related to Biomedical Sciences. 2016 Trends in biochemical sciences
Zhong et al. Sortilin: A novel regulator in lipid metabolism and atherogenesis. 2016 Clinica chimica acta; international journal of clinical chemistry
Apostolopoulou et al. The role of mitochondria in statin-induced myopathy. 2015 Eur J Clin Invest
Eren et al. HDL functionality and crystal-based sterile inflammation in atherosclerosis. 2015 Clin Chim Acta
Grundy Adipose tissue and metabolic syndrome: too much, too little or neither. 2015 Eur J Clin Invest
Gulati and Merz New cholesterol guidelines and primary prevention in women. 2015 Trends Cardiovasc Med
Kobayashi and Mabuchi Lipoprotein lipase and atherosclerosis. 2015 Annals of clinical biochemistry
Langsted and Nordestgaard Nonfasting Lipid Profiles: The Way of the Future. 2015 Clin Chem
Opie Present status of statin therapy. 2015 Trends Cardiovasc Med
Saleheen et al. Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study. 2015 Lancet Diabetes Endocrinol
Tall and Yvan-Charvet Cholesterol, inflammation and innate immunity. 2015 Nat Rev Immunol
van Tienhoven-Wind and Dullaart Low-normal thyroid function and the pathogenesis of common cardio-metabolic disorders. 2015 Eur J Clin Invest